A. I. Shevchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
A. I. Shevchenko has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana Nikolaevna Subbotina
Siberian Federal University; Federal Siberian Research Clinical Center
3 shared publications - A. A. Shalyova
Siberian Federal University; Federal Siberian Scientific Clinical Center
2 shared publications - Array A. Chernova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
1 shared publication - D. V. Kurochkin
Siberian Federal University
1 shared publication E. A. Pozdysheva
Central Research Institute of Epidemiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
1 shared publication- Elena Nikolaevna Voronina
Knorre Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia
1 shared publication
Latest Publications
- 21 November 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10)
Analysis of VDR, ADRB1, SP4, MMP3, and MMP9 gene polymorphisms in patients with Wolff-Parkinson-White syndrome
Aim. To analyze the association of VDR (rs1544410), ADRB1 (rs1801252), SP4 (rs1011168), MMP3 (rs35068180), and MMP9 (rs11697325) gene polymorphisms with Wolff-Parkinson-White syndrome (WPW). Material and methods. A total of 169 patients with WPW syndrome and 158 controls were included in the study. DNA was isolated from whole blood leukocytes using the phenol-chloroform extraction. Commercial kits from OOO NPF Litekh (Moscow) were used for genotyping the rs1544410 and rs11697325 polymorphisms in the VDR and MMP9 genes. Analysis of rs1011168, rs1801252, and rs35068180 was performed using the "PCR-Komplekt" amplification reagent kit ("Sintol", Moscow). Results. When comparing the frequency of the studied polymorphisms between patients with WPW syndrome and the control group, significant differences were found for MMP3 rs35068180 and MMP9 rs11697325. No differences were found for the VDR (rs1544410), ADRB1 (rs1801252), and SP4 (rs1011168) polymorphisms. When comparing the genotype frequencies for the five studied polymorphisms between groups of patients with different clinical variants of WPW syndrome, significant differences were found for SP4 rs1011168 and MMP3 rs35068180. Conclusion. The 5A/5A genotype of the MMP3 gene was shown to reduce the probability of WPW syndrome by almost twofold, while the AA genotype of the MMP9 gene also increased the risk of cardiovascular events by twofold.
- 21 November 2025
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (10)
Analysis of VDR, ADRB1, SP4, MMP3, and MMP9 gene polymorphisms in patients with Wolff-Parkinson-White syndrome
Aim. To analyze the association of VDR (rs1544410), ADRB1 (rs1801252), SP4 (rs1011168), MMP3 (rs35068180), and MMP9 (rs11697325) gene polymorphisms with Wolff-Parkinson-White syndrome (WPW). Material and methods. A total of 169 patients with WPW syndrome and 158 controls were included in the study. DNA was isolated from whole blood leukocytes using the phenol-chloroform extraction. Commercial kits from OOO NPF Litekh (Moscow) were used for genotyping the rs1544410 and rs11697325 polymorphisms in the VDR and MMP9 genes. Analysis of rs1011168, rs1801252, and rs35068180 was performed using the "PCR-Komplekt" amplification reagent kit ("Sintol", Moscow). Results. When comparing the frequency of the studied polymorphisms between patients with WPW syndrome and the control group, significant differences were found for MMP3 rs35068180 and MMP9 rs11697325. No differences were found for the VDR (rs1544410), ADRB1 (rs1801252), and SP4 (rs1011168) polymorphisms. When comparing the genotype frequencies for the five studied polymorphisms between groups of patients with different clinical variants of WPW syndrome, significant differences were found for SP4 rs1011168 and MMP3 rs35068180. Conclusion. The 5A/5A genotype of the MMP3 gene was shown to reduce the probability of WPW syndrome by almost twofold, while the AA genotype of the MMP9 gene also increased the risk of cardiovascular events by twofold.
- Open Access
- 27 January 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (1) , 92-98
Sensitivity evaluation of methods for screening JAK2 exon 12 mutations based on heteroduplex and HRM analysis
Background. According to WHO guidelines, one of the criteria for diagnosis of polycythemia vera is the presence of somatic mutations in exon 12 of the JAK2 gene, but to date there is no universally accepted simple method to analyze these mutations. We have previously proposed two methods for screening such mutations based on heteroduplex and HRM (High Resolution Melt) assays, which are relatively cheap and fast compared to sequencing.Aim. To analyze the sensitivity of these screening methods.Materials and methods. The study used cloned DNA samples from 6 patients with various mutations in exon 12 of the JAK2 gene that we had previously identified, as well as a clone of the corresponding wild-type DNA segment. Dilution of the cloned mutant samples with wild-type clones was performed to obtain samples with different levels of allele burden: 100, 50, 25, 12.5, 6.25, 3.13, 1.56 and 0.78 %. Heteroduplex analysis followed by PAGE (polyacrylamide gel) and HRM analysis was then performed with the diluted samples.Results. The sensitivity threshold of the heteroduplex analysis was found to be between 3.13–6.25 % allele burdens depending on the specific mutation, the sensitivity threshold of the HRM assay was 6.25–12.5 % similarly.Conclusion. Our proposed methods of heteroduplex analysis followed by PAGE and HRM-analysis for the detection of polycythemia vera-specific mutations in exon 12 of the JAK2 gene allow increasing the efficiency of using different types of sequencing and can be used as simpler and less expensive methods of preliminary screening of these mutations.
- 27 January 2024
- Published by Publishing House ABV Press in Oncohematology
- Vol. 19 (1) , 92-98
Open AccessSensitivity evaluation of methods for screening JAK2 exon 12 mutations based on heteroduplex and HRM analysis
Background. According to WHO guidelines, one of the criteria for diagnosis of polycythemia vera is the presence of somatic mutations in exon 12 of the JAK2 gene, but to date there is no universally accepted simple method to analyze these mutations. We have previously proposed two methods for screening such mutations based on heteroduplex and HRM (High Resolution Melt) assays, which are relatively cheap and fast compared to sequencing.Aim. To analyze the sensitivity of these screening methods.Materials and methods. The study used cloned DNA samples from 6 patients with various mutations in exon 12 of the JAK2 gene that we had previously identified, as well as a clone of the corresponding wild-type DNA segment. Dilution of the cloned mutant samples with wild-type clones was performed to obtain samples with different levels of allele burden: 100, 50, 25, 12.5, 6.25, 3.13, 1.56 and 0.78 %. Heteroduplex analysis followed by PAGE (polyacrylamide gel) and HRM analysis was then performed with the diluted samples.Results. The sensitivity threshold of the heteroduplex analysis was found to be between 3.13–6.25 % allele burdens depending on the specific mutation, the sensitivity threshold of the HRM assay was 6.25–12.5 % similarly.Conclusion. Our proposed methods of heteroduplex analysis followed by PAGE and HRM-analysis for the detection of polycythemia vera-specific mutations in exon 12 of the JAK2 gene allow increasing the efficiency of using different types of sequencing and can be used as simpler and less expensive methods of preliminary screening of these mutations.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 12 (2)
Possibility of using donor-specific cell-free DNA as biomarker for assessment of renal graft function
Возможность использования донор-специфической бесклеточной ДНК как биомаркера для оценки функции почечного трансплантата
- 1 January 2024
- Published by Geotar-Media Publishing Group in Clinical and Experimental Surgery. Petrovsky journal
- Vol. 12 (2)
Open AccessPossibility of using donor-specific cell-free DNA as biomarker for assessment of renal graft function
Возможность использования донор-специфической бесклеточной ДНК как биомаркера для оценки функции почечного трансплантата
- Open Access
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 101
ANALYSIS OF THE DYNAMICS OF EPIDEMIOLOGICAL INDICATORS IN RELATION TO TUBERCULOSIS AMONG THE ADULT POPULATION OF THE KRASNODAR TERRITORY FOR 2012-2022
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 101
Open AccessANALYSIS OF THE DYNAMICS OF EPIDEMIOLOGICAL INDICATORS IN RELATION TO TUBERCULOSIS AMONG THE ADULT POPULATION OF THE KRASNODAR TERRITORY FOR 2012-2022